Docetaxel: assessing a range of activity.

M Aapro, E Rowinsky

Journal: Anti-cancer drugs 2001;12 Suppl 1():S1-3

PMID: 11340897

Full Text on Wolters Kluwer View on PubMed

Abstract

Address: Institut Multidisciplinaire d'Oncologie, Clinique de Genolier, CH-1272 Genolier, Switzerland. [email protected]

Link outs

Subscription / membership required

Full Text Sources:

https://journals.lww.com/11340897.pmid

MeSH Terms: Antineoplastic Agents, Phytogenic, Clinical Trials, Phase III as Topic, Docetaxel, Humans, Neoplasms, Paclitaxel, Taxoids

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.